Dr. Divya Bansal is a Consultant – Hematology in the Department of Bone Marrow Transplant at Manipal Hospitals, New Delhi. She has a rich experience of 19 years in the field of Hematology and bone marrow transplant. Her field of interest include Bone Marrow Transplant, Autologous BMT for lymphomas, germ cell tumors, multiple sclerosis, aplastic anemia, thalassemia, Allogeneic BMT for sickle cell anemia and pediatric hematological disorders.
Along with her expertise, she is a Life Member of the Indian Society of Hematology & Blood Transfusion, Indian Medical Association, Delhi Medical Association, and Member of the American Society of Hematology
Dr. Divya Bansal has performed many allogenic bone marrow transplant for thalassemia patients.Thalassemia is a genetic blood disorder that often requires lifelong medical management. Dr. Divya Bansal’s experience in performing allogenic bone marrow transplants for thalassemia patients is crucial because this procedure can offer a potential cure for individuals with severe forms of the disease. Her extensive experience with 800 bone marrow transplants demonstrates her proficiency in this complex and life-saving procedure.The fact that Dr. Bansal attracts patients from advanced countries and regions like Kenya, Sudan, South Sudan, Iraq, Yemen, Somalia, Uzbekistan, and Kyrgyzstan underscores her reputation and expertise in the field. Patients seeking specialized treatments often travel long distances to access her services, which speaks to her standing as a medical expert in her field.
The use of bone marrow transplant or stem cell transplant to treat Multiple Sclerosis is a relatively newer approach, but it shows promise in managing this autoimmune neurological disorder. Dr. Divya Bansal’s specialization in this area indicates her commitment to exploring innovative treatments for challenging conditions like MS.- Mutiple Sclerosis.
Dr. Bansal’s work not only benefits patients in her immediate region but also has a global impact. Her expertise in bone marrow transplantation and the treatment of blood disorders, including thalassemia and Multiple Sclerosis, is likely contributing to advancements in medical science and offering hope to patients worldwide